Company & Sponsor Intelligence

The Cleveland Clinic

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting4

Completed3

Countries1

Therapeutic footprint

alzheimersautismepilepsyparkinsons

Indexed studies

NCT03923920Screening for Systemic Amyloidosis Via the Ligamentum Flavum
alzheimers · United StatesCOMPLETED

NCT02202421T-ABA Group Based Early Intervention For Parents of Children With ASD
autism · United StatesNA

NCT07138560BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
parkinsons · United StatesPHASE4

NCT07748962Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease
parkinsons · United StatesNA

NCT07110376Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
parkinsons · United StatesNA

NCT07442747Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
parkinsons · United StatesPHASE2

NCT04000360Pragmatic Cyclical Lower Extremity Exercise Trial for Parkinson's Disease
parkinsons · United StatesNA

NCT00361010A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
epilepsy · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →